Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD

Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.

  1. 3d ago ·  Video

    257: Digital Cytology and AI in Practice | CorePlus x Epredia at PathVisions 2026

    Send us Fan Mail Can a lab run cytology fully digital, with AI, and still keep rescans near 1%? CorePlus in Puerto Rico has been reading histology digitally since January 1, 2020. Then they took on the hard part: digital cytology. In this talk from the Epredia breakfast workshop at PathVisions 2026, CorePlus founder Mariano de Socarraz walks through six years of building one scanner platform for histology, Pap smears and low-cellularity urine cytology, and where AI paid off. Every AI project in pathology has to pay off three times: for the pathologist, for the business, and for the patient. You'll learn: Why CorePlus went digital on vision and gut feeling, not an ROI spreadsheet, and what "return on innovation" meansHow a prostate AI moved from second read to front-end triage: 99.2% negative predictive value across 9,300+ prostate cases and about 122,000 slidesWhy cytology is harder to scan than histology, and how water immersion scanning cut scan time by 66%How 100% Pap smear QC fits in the time a manual 10% review used to take, and the 245 cases it caughtWhy Mariano calls the 10% review standard "an illusion" (England's NHS has required 100% review since 2003)Urine cytology with AI: 92.5% sensitivity, 98.4% specificity, quantitative N:C ratios, and the fight to bring rescans down from 12%What pathology residents should learn now, and his advice for labs that haven't started Episode Highlights 00:00 - Every AI project has to pay off three times01:15 - Six years of digital pathology at CorePlus02:31 - Starting with vision, not ROI02:57 - Decoupling the pathologist from the glass04:06 - Goals: one scanner platform, redundancy, rescans below 1%07:25 - Prostate AI as a second read: 99.2% negative predictive value09:13 - AI triage on the front end10:12 - Five AI algorithms in routine use10:46 - Why cytology is harder to scan: single layer, extended focus, Z-stacking14:14 - Water immersion cuts scan time by 66%14:41 - 100% Pap smear quality control22:32 - "10% review is an illusion"23:06 - Low-cellularity urine cytology24:28 - 92.5% sensitivity, 98.4% specificity25:41 - From qualitative to quantitative: N:C ratios28:49 - Rescan rates: where they still are32:06 - Takeaways: go digital first, add AI where volume and variability are highest35:53 - Q&A: what should pathology residents learn?40:56 - Return on innovation43:34 - Advice for labs just starting CorePlus publications discussed Rivera Rolon MDM, Gustafson E, Cole R, et al., de Socarraz M, Santa-Rosario JC. Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView System. Cancer Cytopathology, 2025. doi:10.1002/cncy.70019Santa-Rosario JC, Gustafson EA, Sanabria Bellassai DE, Gustafson PE, de Socarraz M. Validation and three years of clinical experience in using an artificial intelligence algorithm as a second read system for prostate cancer diagnosis - real-world experience. Journal of Pathology Informatics, 2024. doi:10.1016/j.jpi.2024.100378 Resources Mentioned Free Digital Pathology 101 book: https://www.aleksandrazuraw.com/bookPathology Visions 2026: https://digitalpathologyassociation.org/pathology-visions-conference This episode is sponsored by Epredia. Thank you for learning with me, trailblazer. If this helped, share it with one colleague in cytology. #DigitalPathology #DigitalCytology #PathologyAI #PathVisions2026 Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  2. 5d ago ·  Video

    256: Digital Pathology 101, 2nd Edition: What Changed and Why | Free Book Launch

    Send us Fan Mail What changes when tissue becomes data? A glass slide is a data point: one person, one place, one moment, then a box in the archive. A digital slide is a data source: it can be shared, measured, reused and revisited. That idea runs through the whole second edition of Digital Pathology 101, and in this live launch I walk you through what changed since the 2023 edition and why. I'm Dr. Aleks Zuraw, a board-certified veterinary and toxicologic pathologist and the host of the Digital Pathology Podcast. I wrote Digital Pathology 101 as the bridge between pathology and computer science that I needed in my first job, as the pathologist on a team of image analysis scientists. The second edition is free as a PDF. What's new in the second edition Five chapters became six, with new formatting and new images (about 130 pages in the first edition, 179 now)AI gets two chapters: Understanding AI in Pathology (computer vision to pathology vision, machine learning fundamentals, foundation models, transfer learning) and Implementing AI in Pathology (generative AI, validation, FDA pathways, bias and ethics, running a digital pathology operation)A rewritten chapter on digital pathology in toxicologic pathology: whole slide imaging, image analysis and AI in nonclinical drug developmentQR codes that take you to the matching podcast episodes and coursesEpisode Highlights 0:00 - Welcome: the second edition and the Tissue Science Club3:23 - Why I wrote Digital Pathology 101 in the first place4:30 - What changed since 2023: remote pathology, AI at scale, foundation models5:53 - Five chapters became six: what's in each one9:18 - Glass slide vs digital slide: data point vs data source13:38 - From scanner to foundation models: which step is your lab at?17:46 - The DigiPath Digest: reading the literature live19:25 - The seven-part AI series in Modern Pathology21:50 - Why real learning takes hours, not minutes23:47 - The Tissue Science Club: every course, monthly lives, your questionsResources Mentioned Digital Pathology 101, 2nd edition (free PDF): https://www.aleksandrazuraw.com/bookTissue Science Club on Skool: https://www.skool.com/tissue-science-club/aboutNot on Amazon yet. I'll let you know when the print version is out. Thank you for learning with me, trailblazer. If this episode helped you, share it with one colleague who's just starting their digital pathology journey. Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  3. Nov 5 ·  Video

    255: Are Robots the Next Big Shift in Digital Pathology | with Trang Vu, PhD

    Send us Fan Mail Robots are reaching the pathology lab, whole slide scanners are back in the spotlight, and pathology AI companies are getting bought. Dr. Aleks Zuraw, board-certified veterinary pathologist and host of the Digital Pathology Podcast, recaps PathVisions 2026, the Digital Pathology Association's annual meeting, with Trang Vu, who comes from the spatial biology side and tracks digital pathology vendors closely. You'll learn: Why hardware and robotics took over the PathVisions exhibit hall this yearWhat makes Grundium's new Ocus R different: independent scanning heads you add over time, a slide tray instead of a doorWhy the biggest whole slide scanner isn't always the right one for your lab's slide volumeHow AxLab's robotic arm feeds slides into a scanner, and why robotics is only now reaching pathologyWhy Philips' DICOM-ready scanner files matter for storage and cloud AIWhy standalone pathology AI companies are partnering with image management systems (IMS)What this year's deals mean: AstraZeneca and Modella, Roche and PathAI, Agilent and ProsciaWhere virtual staining is ready, and where it still needs validation for every markerElsie, the humanoid lab assistant from Tactus AIWho small and remote scanners are for, including a $4,500 option for rural hospitals Chapters 00:00 Elsie: a robot that reloads your scanner overnight 01:05 PathVisions 2026 in 30 seconds 01:42 Meet Trang Vu 03:01 Why PathVisions is "USCAP for the cool kids" 05:03 Hardware is back on the exhibit floor 07:18 Grundium's Ocus R: launch strategy and design 13:17 Do you need a 600-slide scanner? 14:21 AxLab's robotic arm 15:29 Why robots are only now reaching pathology 18:03 Philips and Evident unveil new scanners 18:55 Why pre-show buzz beats a booth unveiling 20:52 Philips: DICOM-ready, smaller whole slide image files 23:20 Pathology AI companies and image management systems 27:55 Modella and AstraZeneca 30:27 "Acquisition row": PathAI, Roche and Proscia 32:26 Agilent's full digital pathology stack 35:16 Virtual staining: where it's ready and where it isn't 39:51 Elsie, the humanoid lab assistant from Tactus AI 44:10 Direct-to-digital imaging and why digitization pays off 47:54 Small and remote whole slide scanners 51:08 A $4,500 remote scanner for rural hospitals 54:00 What's next: USCAP 2027 in Vancouver Good to know: Agilent has signed a definitive agreement to acquire Proscia; the deal hasn't closed yet. Philips' "50% smaller files" is Philips' own up-to figure based on preliminary data. Follow Trang Vu on LinkedIn: https://www.linkedin.com/in/trang-nguyen-vu/  Dr. Beth Plocharczyk's episode on serving two community hospitals with remote scanners:  https://digitalpathologyplace.com/podcast/digital-pathology-for-community-hospitals-dr-elizabeth-plocharczyk/ Free Digital Pathology 101 book: https://www.aleksandrazuraw.com/book Paid partnership with Hamamatsu. #DigitalPathology #PathVisions2026 #WholeSlideImaging #LabAutomation #PathologyAI Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  4. Oct 30 ·  Video

    254: Digital Pathology Q&A: How to Get Started | PathVisions 2026

    Send us Fan Mail Is a digital slide as good as glass? Live from the Hamamatsu booth at PathVisions 2026, Dr. Aleks Zuraw and Amy Welch, Product Marketing Manager for NanoZoomer at Hamamatsu, open the question box and answer the beginner questions attendees dropped in all week. Elizabeth Blakely joins as a surprise guest. You'll learn: Whether a digital slide is as good as glass for diagnosisHow long it takes to scan a slide, and why the 15 x 15 mm benchmark means little to a pathologistHow a whole slide scanner turns a glass slide into a digital imageWhether AI will replace pathologistsWhy a digital slide is a data source, not a data pointThe parts of the digital pathology workflow, from pre-analytics to AIWhat to learn first if you're new to the field Chapters 00:00 Live from PathVisions 2026 with Amy Welch 00:56 Is a digital slide as good as glass? 02:49 What the NanoZoomer numbers mean 03:22 How long does it take to scan a slide? 05:14 What surprised us most when we started in digital pathology 09:29 Is there a scanner for small volumes? 10:15 Will AI replace pathologists? 16:42 Pathology clinics: patients seeing their own slides 17:44 How does a whole slide scanner work? 21:11 What is digital pathology? 25:14 Digital pathology in 25 years 26:07 Surprise guest: Elizabeth Blakely 29:33 Direct-to-digital tissue imaging 32:22 The parts of the digital pathology workflow 35:03 What should someone new to digital pathology learn first? 38:09 Why "15 x 15 mm in 30 seconds" means nothing to a pathologist 39:46 Where to learn more: Digital Pathology 101 In partnership with Hamamatsu. Free Digital Pathology 101 book: https://www.aleksandrazuraw.com/book #DigitalPathology #PathVisions2026 #WholeSlideImaging #NanoZoomer #PathologyAI Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  5. Oct 27 ·  Video

    253: What Happens After Your Whole Slide Scanner Arrives? | PathVisions 2026

    Send us Fan Mail What happens after your whole slide scanner arrives in the lab? Live from the Hamamatsu booth at PathVisions 2026, Dr. Aleks Zuraw meets the people who help labs go digital, plus a surprise guest from the DICOM standard. In this episode: David Clunie of DICOM Working Group 26 on the PathVisions 2026 DICOM Connectathon: scanners, archives, viewers and annotation tools from different vendors working together, and the new work on annotations with holesStephanie Fullerton introduces two new members of the Hamamatsu teamJessica Calafati, NanoZoomer national sales manager, on why going digital is easier than it was 10 years ago, what to do about a high rescan rate, and why your scanner and image management system (IMS) vendors need to talk before every upgradeGary Davis, business development manager for MoxiePlex, on multiplex fluorescence imaging and spectral unmixing Chapters 00:00 What happens after your whole slide scanner arrives 00:26 Live from the Hamamatsu booth at PathVisions 2026 01:07 David Clunie on the DICOM Connectathon results 02:48 DICOM annotations: contours within contours 05:06 Hamamatsu's new team members 06:09 Jessica Calafati: why going digital is easier now 07:47 How to fix a high rescan rate 09:29 Why scanner and software teams need to talk 09:59 Gary Davis on MoxiePlex 11:18 Spectral unmixing in three sentences 12:41 Send us your scanner questions Free Digital Pathology 101 book: https://www.aleksandrazuraw.com/book In partnership with Hamamatsu. #DigitalPathology #WholeSlideImaging #DICOM Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  6. Oct 18

    252: Digital Pathology Trends 2026: Agilent Buys Proscia | PathVisions

    Send us Fan Mail What are the biggest digital pathology trends of 2026, and what does Agilent buying Proscia tell us? It's the clearest sign yet that the field is moving from shiny algorithms to full, connected workflows. In this live recap from Pathology Visions 2026 in San Diego, Dr. Aleks Zuraw (DVM, PhD, DACVP), board-certified veterinary pathologist and host of the Digital Pathology Podcast, sits down with Imogen Fitt of Signify Research to break down the biggest news of the week and the trends behind it. Imogen tracks the digital pathology market for a living. Aleks brings the pathologist's view. Together they cover the Agilent and Proscia deal, why software is finally being built around pathologist ergonomics, how scanner differences can change AI results, and whether every AI tool needs FDA clearance or can live as a lab-developed test (LDT). Key takeaways - Agilent's acquisition of Proscia is the peak of a partnership trend: everyone wants to be compatible with everyone. - This year's software news centers on ergonomics, voice dictation and voice AI, not just new algorithms. - PathVisions posters compared scanners and showed that image differences between models can change AI output. Purpose and intended use have to be defined within a whole system. - "Good enough" can be the right specification when AI is a safety net that flags cases for a human. - Not everything needs to be a medical device. The LDT pathway lets single labs start, gather data, and decide later whether to pursue clearance. - Pay-per-scan models and implementation work, not hype, are what will get digital pathology to more labs. Episode Highlights 00:36 - Agilent acquires Proscia - The biggest digital pathology news heading into PathVisions. 01:10 - Aperture and Concentriq - AI that finds clinical trial patients and an AI-enabled image management system. 01:43 - Ergonomics and voice AI - Why nobody likes pop-up windows, and what's replacing them. 02:16 - From staining to sign-out - Aleks recalls first seeing Agilent's full workflow at USCAP. 03:39 Scanners change AI output - What this year's posters showed, and why it surprised a pathologist. 05:09 - Good enough vs perfect - Imogen plays devil's advocate on accuracy targets. 07:15 - The pixel pathway - How locked systems ended up driving interoperability. 08:02 - FDA clearance or LDT? - Does every pathology AI tool need to be a medical device? 11:03 - Implementation over hype - Why the "boring" topics are the real progress. 12:03 - Pay-per-scan - Getting digital pathology to labs that can't buy a scanner upfront. Resources Mentioned - Signify Research: https://www.signifyresearch.net/ - Pathology Visions 2026: https://digitalpathologyassociation.org/pathology-visions-conference - Free Digital Pathology 101 book: https://www.aleksandrazuraw.com/book Connect with Imogen Fitt on LinkedIn: https://www.linkedin.com/in/imogen-fitt-194566127/ Enjoyed this episode? Share it with one colleague who's still deciding whether to go digital. Support the show Get the "Digital Pathology 101" FREE E-book and join us!

  7. Oct 15

    251: Pathology Foundation Models: PathBench, Scanner Shift, and the HER2 Slide Swing

    Send us Fan Mail What if changing the scanner or choosing another slide from the same tumor changes your pathology AI results? In DigiPath Digest #52, I review three studies on pathology foundation models, scanner shift, and slide selection to ask how much of “model performance” comes from the model itself. We look at a benchmark comparing 32 foundation models across 41 tasks, a study testing 10 models across scanners and centers, and a breast cancer study examining how predictions change when different slides represent the same patient. The findings challenge familiar assumptions about bigger models, benchmark rankings, and the idea that one slide can represent a heterogeneous tumor. Combining information from multiple slides improved performance in the breast cancer study, without changing the model architecture. My takeaway: evaluate the model, the data, and the workflow together. I share three practical questions to ask before accepting an AI benchmark score. Highlights with Timestamps 00:42 — PathVisions updates and plans for conference activities.05:09 — Trailblazer podcast interviews: sharing real implementation experience.08:02 — How much of foundation model performance comes from the model?13:16 — The 32-model benchmark and closely grouped leading scores.16:06 — Why bigger models do not consistently perform better on unfamiliar data.18:58 — Scanner shift and testing models on scanners held out during training.22:18 — Why AUROC alone can miss important performance losses.24:55 — Use-case-specific validation and the “pixel pathway” from scanning to diagnosis.28:37 — Slide selection, tumor heterogeneity, and HER2 prediction.33:46 — Combining slides from the same patient: performance gains and computational cost.35:31 — Three questions to ask before trusting a benchmark.37:27 — Audience Q&A on available datasets and checking AI-generated answers.40:39 — Plans for the Digital Pathology Club and more accessible expert guidance.Resource from this episode Research papers: A benchmark study of vision and pathology foundation models for computational pathologyDomain Generalization of Histopathology Foundation Models in Multicenter, Multi-Scanner Cohorts: A Comparative BenchmarkSlide Selection Introduces Sampling-Induced Prediction Uncertainty in Digital Pathology AI: Evidence from Multi-Slide Breast Cancer CohortsData resource mentioned: The Cancer Genome Atlas (TCGA) through the Genomic Data Commons (GDC) portalSupport the show Get the "Digital Pathology 101" FREE E-book and join us!

  8. Oct 8

    250: AI for Scientific Writing: 4 Rules from a Pathologist

    Send us Fan Mail Can you use AI to write scientific papers without fabricated references, journal trouble or learning to code? I recorded this episode at the airport on my way to ESTP 2026 in Kraków. It's my practice run of the talk I gave there. When deep learning came into pathology, people asked me if I was going to learn to code. I decided no. Large language models kind of proved me right. In this episode I walk you through how I use LLMs for writing papers, responding to co-authors, building slides and even running code, and the four rules that keep it safe: Domain expertise is the promptSupply the sourcesEncode correctionsThe subject matter expert verifiesIn this episode: What the LLM does vs. what the pathologist does, task by taskWhat Toxicologic Pathology, Veterinary Pathology and Elsevier journals require when you disclose AI usePathology LLM tools already working on tox study reports, image analysis and whole slide imagesThe reference I didn't check that almost cost me a publicationWhy an LLM will happily justify switching patients from Tylenol to acetaminophenAutomation bias, model bias, and how to start with the tools your institution has approvedGoing to PathVisions 2026 in San Diego, Oct 16-18? Find me at the Hamamatsu booth #201. I'm also recording 8 short podcast interviews on site, Saturday and Sunday. Share your digital pathology story, grab a slot: https://calendar.google.com/calendar/appointments/schedules/AcZssZ0yjFhaL0kGJ7bZ18oITwyw-qY2yxvcDEyfqpj3LBulrRdiO4fRUkgM0Avlj_oJkIaw-0ZjhaC9 Links Free book, Digital Pathology 101: https://www.aleksandrazuraw.com/book Related episode: How to teach AI to healthcare professionals, with Dr. Candice Chu:  Watch the video version on YouTube: https://youtu.be/eY7UywT-zRM?si=qK88eECJqoA-DqKF References Zuraw & Aeffner, Vet Pathol 2022. doi:10.1177/03009858211040484 Turner et al., Toxicol Pathol 2021. doi:10.1177/0192623321990375 Thirunavukarasu et al., Nat Med 2023. doi:10.1038/s41591-023-02448-8 Lu et al., J Transl Med 2026. doi:10.1186/s12967-026-08829-0 Doktorova et al., Arch Toxicol 2026. doi:10.1007/s00204-026-04414-y Trost et al., Nat Med 2026. doi:10.1038/s41591-026-04357-y Chen Y et al., Nat Cancer 2026. doi:10.1038/s43018-026-01220-4 Chu, Front Vet Sci 2024. doi:10.3389/fvets.2024.1395934 Jain et al., Cureus 2025. doi:10.7759/cureus.81618 Kurland et al., Neurosurgery 2025. doi:10.1227/neu.0000000000003354 Painter et al., JAMIA Open 2025. doi:10.1093/jamiaopen/ooaf003 Chen S et al., NPJ Digit Med 2025. doi:10.1038/s41746-025-02008-z Dratsch et al., Radiology 2023. doi:10.1148/radiol.222176 Zack et al., Lancet Digit Health 2024. doi:10.1016/S2589-7500(23)00225-X FDA Warning Letter 722591, Apr 2026 EMA/FDA, Guiding principles of good AI practice in drug development, Jan 2026 Huang & Chu, Front Vet Sci 2026. doi:10.3389/fvets.2026.1801756 Support the show Get the "Digital Pathology 101" FREE E-book and join us!

5
out of 5
8 Ratings

About

Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.

You Might Also Like